These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28377059)

  • 1. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors.
    Ramachandran SA; Jadhavar PS; Miglani SK; Singh MP; Kalane DP; Agarwal AK; Sathe BD; Mukherjee K; Gupta A; Haldar S; Raja M; Singh S; Pham SM; Chakravarty S; Quinn K; Belmar S; Alfaro IE; Higgs C; Bernales S; Herrera FJ; Rai R
    Bioorg Med Chem Lett; 2017 May; 27(10):2153-2160. PubMed ID: 28377059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design.
    Machiraju PK; Yedla P; Gubbala SP; Bohari T; Abdul JKV; Xu S; Patel R; Chittireddy VRR; Boppana K; Jagarlapudi SARP; Neamati N; Syed R; Amanchy R
    Comput Biol Chem; 2019 Jun; 80():374-383. PubMed ID: 31103918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties.
    Lee JW; Park J; Kim J; Kim J; Choi C; Min KH
    Eur J Med Chem; 2021 Apr; 216():113298. PubMed ID: 33689933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5- d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors.
    Xun Q; Zhang Z; Luo J; Tong L; Huang M; Wang Z; Zou J; Liu Y; Xu Y; Xie H; Tu ZC; Lu X; Ding K
    J Med Chem; 2018 Mar; 61(6):2353-2371. PubMed ID: 29499108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R.
    Czako B; Marszalek JR; Burke JP; Mandal P; Leonard PG; Cross JB; Mseeh F; Jiang Y; Chang EQ; Suzuki E; Kovacs JJ; Feng N; Gera S; Harris AL; Liu Z; Mullinax RA; Pang J; Parker CA; Spencer ND; Yu SS; Wu Q; Tremblay MR; Mikule K; Wilcoxen K; Heffernan TP; Draetta GF; Jones P
    J Med Chem; 2020 Sep; 63(17):9888-9911. PubMed ID: 32787110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.
    Farag AK; Hassan AHE; Jeong H; Kwon Y; Choi JG; Oh MS; Park KD; Kim YK; Roh EJ
    Eur J Med Chem; 2019 Jan; 162():161-175. PubMed ID: 30445265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
    Wen J; Wang S; Guo R; Liu D
    Eur J Med Chem; 2023 Jan; 245(Pt 1):114884. PubMed ID: 36335744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of (R)-1-arylsulfonylpiperidine-2-carboxamides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Xia G; Liu L; Liu H; Yu J; Xu Z; Chen Q; Ma C; Li P; Xiong B; Liu X; Shen J
    ChemMedChem; 2013 Apr; 8(4):577-81. PubMed ID: 23471829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase Inhibitor.
    Uesato N; Miyagawa N; Inagaki K; Kakefuda R; Kitagawa Y; Matsuo Y; Yamaguchi T; Hata T; Ikegashira K; Matsushita M
    Biol Pharm Bull; 2020; 43(2):325-333. PubMed ID: 32009119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R.
    Liu YQ; Wang YN; Lu XY; Tong LJ; Li Y; Zhang T; Xun QJ; Feng F; Chen YZ; Su Y; Shen YY; Chen Y; Geng MY; Ding K; Li YL; Xie H; Ding J
    Acta Pharmacol Sin; 2018 Nov; 39(11):1768-1776. PubMed ID: 29968849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.
    O'Brien SA; Orf J; Skrzypczynska KM; Tan H; Kim J; DeVoss J; Belmontes B; Egen JG
    Cancer Immunol Immunother; 2021 Aug; 70(8):2401-2410. PubMed ID: 33511454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents.
    Yeung KS; Qiu Z; Xue Q; Fang H; Yang Z; Zadjura L; D'Arienzo CJ; Eggers BJ; Riccardi K; Shi PY; Gong YF; Browning MR; Gao Q; Hansel S; Santone K; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):198-202. PubMed ID: 23200252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect.
    Chompunud Na Ayudhya C; Graidist P; Tipmanee V
    Sci Rep; 2024 May; 14(1):12531. PubMed ID: 38822100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors.
    Jonckers TH; Rouan MC; Haché G; Schepens W; Hallenberger S; Baumeister J; Sasaki JC
    Bioorg Med Chem Lett; 2012 Aug; 22(15):4998-5002. PubMed ID: 22765892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors.
    Liang X; Wang C; Wang B; Liu J; Qi S; Wang A; Liu Q; Deng M; Wang L; Liu J; Liu Q
    Eur J Med Chem; 2022 Dec; 243():114782. PubMed ID: 36179404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).
    Mata G; Miles DH; Drew SL; Fournier J; Lawson KV; Mailyan AK; Sharif EU; Yan X; Beatty JW; Banuelos J; Chen J; Ginn E; Chen A; Gerrick KY; Pham AT; Wong K; Soni D; Dhanota P; Shaqfeh SG; Meleza C; Narasappa N; Singh H; Zhao X; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
    J Med Chem; 2022 Jan; 65(2):1418-1444. PubMed ID: 34672584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitors.
    Certal V; Halley F; Virone-Oddos A; Filoche-Rommé B; Carry JC; Gruss-Leleu F; Bertin L; Guizani H; Pilorge F; Richepin P; Karlsson A; Charrier V; Abecassis PY; Vincent L; Nicolas JP; Lengauer C; Garcia-Echeverria C; Schio L
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1506-10. PubMed ID: 24560540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
    Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Lira R; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Vetelino BC; Xie L; Zhang L; Pustilnik LR; Wood KM; O'Donnell CJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2906-11. PubMed ID: 22429469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.